TABLE 2.
Factor | Estimate ± SE |
P value |
Reliability (%)* |
---|---|---|---|
Overall | |||
Higher preoperative TR | 100 | ||
1+vs 0 | 0.13 ± 0.047 | .006 | |
2+vs 0 | 0.45 ± 0.047 | <.0001 | |
3+/4+vs 0 | 0.50 ± 0.051 | <.0001 | |
Higher heart rate† | −0.16 ± 0.079 | .05 | 60 |
Larger LA area in systole‡ | −4.9 ± 1.8 | .005 | 99 |
Lower LVejection fraction§ | 0.22 ± 0.087 | .01 | 65 |
Higher BUN‖ | 0.052 ± 0.019 | .005 | 77 |
Early phase | |||
Shorter RV base to apex length¶ | −0.76 ± 0.41 | .06 | 85 |
TV procedure | 1.04 ± 0.52 | .03 | |
Late phase | |||
Lower TV fractional shortening# | −7.04 ± 4.02 | .07 | 88 |
Higher bilirubin** | 0.72 ± 0.24 | .006 | 83 |
No TV procedure | −0.72 ± 0.26 | .006 |
BUN, Blood urea nitrogen; LA, left atrial; LV, left ventricular; RV, right ventricular; SE, standard error; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation; TV, tricuspid valve.
Percentage of times factor appeared in 500 bootstrap models.
(75/heart rate), inverse transformation.
(1/LA area in systole), inverse transformation.
(50/LV ejection fraction), inverse transformation.
(BUN/20)2, squared transformation.
(RV base to apex length/7)2, squared transformation.
(TV fractional shortening)2, squared transformation.
Ln(bilirubin), natural logarithmic transformation.